ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2026
Laser interstitial thermal therapy in pediatric neurosurgery: a prospective nationwide study on indications, safety, and early outcomes.
Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate indications, safety, and early outcomes of MRI-guided laser interstitial thermal therapy (LITT) in a nationwide prospective pediatric cohort and to assess the feasibility of same-session stereotactic biopsy.
methodsAll consecutive pediatric patients (≤ 18 years) who underwent LITT at the Danish National Referral Center between June 2021 and October 2025 were prospectively enrolled. Demographic, clinical, radiological, and surgical variables were recorded. Safety outcomes included complications, neurological deficits, length of stay, and 30-day readmission. Seizure outcomes were assessed by Engel classification and tumor response on follow-up MRI.
resultsA total of 27 children (mean age 11.6 ± 4.3 years) underwent LITT, including 18 treated for drug-resistant epilepsy and 9 for tumor indications. Same-session stereotactic biopsy was performed in 10 patients without biopsy-related complications or interference with ablation. Transient neurological deficits were observed in 5 patients and persistent deficits in 3. Hospital stay was 1-2 days in 23 patients, and no 30-day readmissions occurred. Seizure freedom (Engel class I) was achieved in 67% and 50% at 12 and 24 months, respectively. In tumor patients, clinical and MRI follow-up were available in all 9 patients, with one radiographic recurrence during follow-up.
conclusionIn this nationwide prospective cohort of 27 consecutively treated children, LITT demonstrated a favorable safety profile across epilepsy and tumor indications. Same-session stereotactic biopsy was feasible and safe, supporting LITT as a minimally invasive option in carefully selected pediatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.